503 related articles for article (PubMed ID: 15820486)
1. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
[TBL] [Abstract][Full Text] [Related]
2. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Deepa PR; Varalakshmi P
Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
[TBL] [Abstract][Full Text] [Related]
3. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative.
Kumar SA; Sudhahar V; Varalakshmi P
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):25-31. PubMed ID: 16737804
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2004 Jan; 339(1-2):105-15. PubMed ID: 14687900
[TBL] [Abstract][Full Text] [Related]
5. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
6. Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences.
Deepa PR; Varalakshmi P
Mol Cell Biochem; 2003 Dec; 254(1-2):111-6. PubMed ID: 14674688
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant and anti-atherogenic activities of three Piper species on atherogenic diet fed hamsters.
Agbor GA; Vinson JA; Sortino J; Johnson R
Exp Toxicol Pathol; 2012 May; 64(4):387-91. PubMed ID: 21035316
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia.
Kumar SA; Sudhahar V; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):197-204. PubMed ID: 15820496
[TBL] [Abstract][Full Text] [Related]
9. Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet.
Wu Y; Li J; Wang J; Si Q; Zhang J; Jiang Y; Chu L
J Ethnopharmacol; 2009 Apr; 122(3):509-16. PubMed ID: 19429321
[TBL] [Abstract][Full Text] [Related]
10. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet.
Deepa PR; Varalakshmi P
Hum Exp Toxicol; 2003 May; 22(5):229-35. PubMed ID: 12774884
[TBL] [Abstract][Full Text] [Related]
11. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
12. The effect of aspirin on atherogenic diet-induced diabetes mellitus.
Sethi A; Parmar HS; Kumar A
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):371-7. PubMed ID: 21205219
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
[TBL] [Abstract][Full Text] [Related]
14. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
15. Suppression of atherogenesis in hypercholesterolemic rabbits by chondroitin-6-sulfate.
Matsushima T; Nakashima Y; Sugano M; Tasaki H; Kuroiwa A; Koide O
Artery; 1987; 14(6):316-37. PubMed ID: 3118854
[TBL] [Abstract][Full Text] [Related]
16. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
17. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit.
Zulkhairi A; Zaiton Z; Jamaluddin M; Sharida F; Mohd TH; Hasnah B; Nazmi HM; Khairul O; Zanariyah A
Biomed Pharmacother; 2008 Dec; 62(10):716-22. PubMed ID: 18538528
[TBL] [Abstract][Full Text] [Related]
18. Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbits.
Augusti PR; Conterato GM; Somacal S; Sobieski R; Quatrin A; Maurer L; Rocha MP; Denardin IT; Emanuelli T
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):314-22. PubMed ID: 19846890
[TBL] [Abstract][Full Text] [Related]
19. Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet.
Küskü-Kiraz Z; Mehmetçik G; Dogru-Abbasoglu S; Uysal M
Phytother Res; 2010 Apr; 24(4):565-70. PubMed ID: 19777605
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering effect of molluscan (Katelysia opima) glycosaminoglycan (GAG) in hypercholesterolemic induced rats.
Pandian V; Aravindan N; Subramanian S; Somasundaran ST
Biol Chem; 2014 Mar; 395(3):355-64. PubMed ID: 24150207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
